{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:51:08Z","timestamp":1786989068701,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":546,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.exphem.2020.11.004","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T21:41:13Z","timestamp":1605044473000},"page":"61-69.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Generation of a lenalidomide-sensitive syngeneic murine in vivo multiple myeloma model by expression of Crbn"],"prefix":"10.1016","volume":"93","author":[{"given":"Linda","family":"R\u00f6hner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuen Lam Dora","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Scheffold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"K\u00f6pff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Brandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Beilhack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kr\u00f6nke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2020.11.004_bib0001","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","article-title":"A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma","volume":"335","author":"Attal","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2020.11.004_bib0002","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2141.2011.08573.x","article-title":"Guidelines for the diagnosis and management of multiple myeloma 2011","volume":"154","author":"Bird","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2020.11.004_bib0003","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","article-title":"Improved survival in multiple myeloma and the impact of novel therapies","volume":"111","author":"Kumar","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.11.004_bib0004","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0140-6736(62)92665-X","article-title":"Thalidomide and congenital abnormalities [Letter to the Editor]","volume":"279","author":"Lenz","year":"1962","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2020.11.004_bib0005","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(61)90927-8","article-title":"Thalidomide and congenital abnormalities","volume":"278","author":"McBride","year":"1961","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2020.11.004_bib0006","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0041-008X(65)90095-5","article-title":"Teratogenic effects of thalidomide in rabbits, rats, hamsters, and mice","volume":"7","author":"Fratta","year":"1965","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.exphem.2020.11.004_bib0007","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1177319","article-title":"Identification of a primary target of thalidomide teratogenicity","volume":"327","author":"Ito","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.exphem.2020.11.004_bib0008","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1244851","article-title":"Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells","volume":"343","author":"Kr\u00f6nke","year":"2014","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.exphem.2020.11.004_bib0009","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/bjh.12708","article-title":"Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4CRBN","volume":"164","author":"Gandhi","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2020.11.004_bib0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.1244917","article-title":"The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins","volume":"343","author":"Lu","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.exphem.2020.11.004_bib0011","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1182\/blood-2014-02-557819","article-title":"Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma","volume":"124","author":"Zhu","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.11.004_bib0012","doi-asserted-by":"crossref","DOI":"10.4161\/21624011.2014.941742","article-title":"Lenalidomide induces degradation of IKZF1 and IKZF3","volume":"3","author":"Kr\u00f6nke","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.exphem.2020.11.004_bib0013","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nature16979","article-title":"Structural basis of lenalidomide-induced CK1alpha degradation by the CRL4(CRBN) ubiquitin ligase","volume":"532","author":"Petzold","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2020.11.004_bib0014","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature13527","article-title":"Structure of the DDB1\u2013CRBN E3 ubiquitin ligase in complex with thalidomide","volume":"512","author":"Fischer","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2020.11.004_bib0015","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1182\/blood-2012-02-412783","article-title":"Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy","volume":"120","author":"Chesi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.11.004_bib0016","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1182\/blood-2018-05-852798","article-title":"CrbnI391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice","volume":"132","author":"Fink","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.11.004_bib0017","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nature14610","article-title":"Lenalidomide induces ubiquitination and degradation of CK1alpha in del(5q) MDS","volume":"523","author":"Kr\u00f6nke","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2020.11.004_bib0018","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1074\/jbc.M117.816868","article-title":"Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon","volume":"293","author":"Akuffo","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2020.11.004_bib0019","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41589-018-0129-x","article-title":"SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate","volume":"14","author":"Matyskiela","year":"2018","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.exphem.2020.11.004_bib0020","doi-asserted-by":"crossref","first-page":"e38430","DOI":"10.7554\/eLife.38430","article-title":"Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome","volume":"7","author":"Donovan","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.exphem.2020.11.004_bib0021","doi-asserted-by":"crossref","first-page":"e52398","DOI":"10.1371\/journal.pone.0052398","article-title":"Non-invasive imaging provides spatiotemporal information on disease progression and response to therapy in a murine model of multiple myeloma","volume":"7","author":"Riedel","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2020.11.004_bib0022","doi-asserted-by":"crossref","first-page":"e51892","DOI":"10.1371\/journal.pone.0051892","article-title":"A novel mouse model for multiple myeloma (MOPC315.BM) that allows noninvasive spatiotemporal detection of osteolytic disease","volume":"7","author":"Hofgaard","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2020.11.004_bib0023","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4161\/mabs.26709","article-title":"A novel llama antibody targeting Fn14 exhibits anti-metastatic activity in vivo","volume":"6","author":"Trebing","year":"2014","journal-title":"MAbs"},{"key":"10.1016\/j.exphem.2020.11.004_bib0024","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1172\/JCI69094","article-title":"GP130 activation induces myeloma and collaborates with MYC","volume":"124","author":"Dechow","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2020.11.004_bib0025","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.3324\/haematol.2019.221127","article-title":"Osteolytic disease in IL-6 and Myc dependent mouse model of human myeloma","volume":"105","author":"Sun","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2020.11.004_bib0026","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1158\/0008-5472.CAN-06-3699","article-title":"A transgenic mouse model of plasma cell malignancy shows phenotypic, cytogenetic, and gene expression heterogeneity similar to human multiple myeloma","volume":"67","author":"Boylan","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2020.11.004_bib0027","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/path.2714","article-title":"Anaplastic plasmacytoma of mouse\u2014establishing parallels between subtypes of mouse and human plasma cell neoplasia","volume":"221","author":"de Jong","year":"2010","journal-title":"J Pathol"},{"key":"10.1016\/j.exphem.2020.11.004_bib0028","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1021\/bi00851a048","article-title":"Mouse myeloma proteins with antihapten antibody acitivity. The protein produced by plasma cell tumor MOPC-315","volume":"7","author":"Eisen","year":"1968","journal-title":"Biochemistry"},{"key":"10.1016\/j.exphem.2020.11.004_bib0029","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/bjc.1990.51","article-title":"The 5T mouse multiple myeloma model: absence of c-myc oncogene rearrangement in early transplant generations","volume":"61","author":"Radl","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1016\/j.exphem.2020.11.004_bib0030","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/febs.13633","article-title":"Potential crosstalk of the interleukin-6-heme oxygenase-1-dependent mechanism involved in resistance to lenalidomide in multiple myeloma cells","volume":"283","author":"Wu","year":"2016","journal-title":"FEBS J"},{"key":"10.1016\/j.exphem.2020.11.004_bib0031","doi-asserted-by":"crossref","first-page":"11802","DOI":"10.1073\/pnas.1814446115","article-title":"Humanized cereblon mice revealed two distinct therapeutic pathways of immunomodulatory drugs","volume":"115","author":"Gemechu","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2020.11.004_bib0032","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1182\/blood-2005-01-0373","article-title":"A clinically relevant SCID-hu in vivo model of human multiple myeloma","volume":"106","author":"Tassone","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.11.004_bib0033","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/leu.2010.300","article-title":"A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells","volume":"25","author":"Calimeri","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2020.11.004_bib0034","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1158\/0008-5472.CAN-16-1260","article-title":"Humanized mouse xenograft models: narrowing the tumor\u2013microenvironment gap","volume":"76","author":"Morton","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2020.11.004_bib0035","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/cmi.2012.2","article-title":"Current advances in humanized mouse models","volume":"9","author":"Ito","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.exphem.2020.11.004_bib0036","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/nm.4202","article-title":"Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice","volume":"22","author":"Das","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2020.11.004_bib0037","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccr.2008.01.007","article-title":"AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies","volume":"13","author":"Chesi","year":"2008","journal-title":"Cancer Cell"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X20306226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X20306226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:37:06Z","timestamp":1759567026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X20306226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":37,"alternative-id":["S0301472X20306226"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2020.11.004","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of a lenalidomide-sensitive syngeneic murine in vivo multiple myeloma model by expression of CrbnI391V","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2020.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}